CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Medicis Pharmaceutical Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Medicis Pharmaceutical Corp
7720 Dobson Road
Phone: (212) 599-2000p:212 599-2000 SCOTTSDALE, AZ  85256  United States Ticker: MRXMRX

This company was Merged or Acquired on 12/11/2012.
This company ceased filing statements with the SEC on 12/26/2012.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Medicis Pharmaceutical Corp is a United States-based specialty pharmaceutical company. The Company offers a range of products for various conditions or aesthetic improvements including facial wrinkles, glabellar lines, acne, fungal infections, hyperpigmentation, photoaging, psoriasis, actinic keratosis, bronchospasms, external genital and perianal warts/condyloma acuminate, seborrheic dermatitis and cosmesis (improvement in the texture and appearance of skin). Its brands include DYSPORT, PERLANE, RESTYLANE, SOLODYN, VANOS, ZIANA and ZYCLARA.
(Source: 10-Q)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201212/31/2011YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Vice President, General Counsel, Secretary, Director Robert R.Chai-Onn 44 12/11/2012 12/11/2012
Officer, Director Howard B.Schiller 53 12/11/2012 12/11/2012
Officer, Director RyanWeldon 12/11/2012 12/11/2012

Business Names
Business Name
Dermavest Swedish Holdings AB
Dermavest, Inc.
Graceway Pharmaceuticals LLC
9 additional Business Names available in full report.

General Information
Number of Employees: 646 (As of 12/31/2011)
Outstanding Shares: 58,393,411 (As of 11/5/2012)
Shareholders: 160
Stock Exchange: NYSE
Federal Tax Id: 521574808
Fax Number: (302) 655-5049
Email Address: info@medicis.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023